# Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-phase-iii-keynote-181-study-of-pembrolizumab-versus-chemotherapy-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Takashi Kojima,Manish A. Shah,Kei Muro,Éric François,Antoine Adenis,Chih‐Hung Hsu,Toshihiko Doi,Toshikazu Moriwaki,Sung‐Bae Kim,Se‐Hoon Lee,Jaafar Bennouna,Ken Kato,Lin Shen,Peter C. Enzinger,Shukui Qin,Paula Ferreira,Jia Chen,Gustavo Girotto,Christelle de la Fouchardière,Hélène Senellart,Raed Moh’d Taiseer Al-Rajabi,Florian Lordick,Ruixue Wang,Shailaja Suryawanshi,Pooja Bhagia,Soonmo Peter Kang,Jean‐Philippe Metges,on behalf of the KEYNOTE-181 Investigators |
| Citations | 1,190 |
| DOI | 10.1200/jco.20.01888 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3092384992 |
| PMID | 33026938 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Se‐Hoon Lee](https://scholariq.org/researchers/se-hoon-lee/)
- [Jia Chen](https://scholariq.org/researchers/jia-chen/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)

## Paper topics

- [Esophageal Cancer Research and Treatment](https://scholariq.org/topics/esophageal-cancer-research-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.